A Study to Evaluate Symptomatic Remission in Schizophrenia With Long Acting Risperidone Microspheres
Clinical trial NCT00216528 · COMPLETED
Trial details
- NCT number
- NCT00216528
- Sponsor
- Janssen Korea, Ltd., Korea
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2005-07-01
- Enrollment
- 527
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.